Key result
Mobile health interventions show weak evidence for reducing CVD and type 2 diabetes risk.
Why the study?
Digital technology offers opportunities for broad public health reach, but the effectiveness of mobile health-based interventions in reducing cardiovascular disease and type 2 diabetes risk required systematic evaluation.
Do mobile health-based interventions reduce the risk of cardiovascular disease and type 2 diabetes mellitus?
Systematic Review
Do mobile health-based interventions reduce the risk of cardiovascular disease and type 2 diabetes mellitus?
Current evidence for mobile health interventions in preventing CVD and type 2 diabetes is of low quality, with modest effects primarily seen in weight and BMI reduction.
Clinicians should not adopt mobile health interventions for CVD or T2D prevention; higher-quality RCTs are required to establish benefit.
BACKGROUND: Digital technology is an opportunity for public health interventions to reach a large part of the population. OBJECTIVE: This systematic literature review aimed to assess the effectiveness of mobile health-based interventions in reducing the risk of cardiovascular disease and type 2 diabetes mellitus. METHODS: We conducted the systematic search in 7 electronic databases using a predefined search strategy. We included articles published between inception of the databases and March 2019 if they reported on the effectiveness of an intervention for prevention of cardiovascular disease or type 2 diabetes via mobile technology. One researcher performed the search, study selection, data extraction, and methodological quality assessment. The steps were validated by the other members of the research team. RESULTS: The search yielded 941 articles for cardiovascular disease, of which 3 met the inclusion criteria, and 732 for type 2 diabetes, of which 6 met the inclusion criteria. The methodological quality of the studies was low, with the main issue being nonblinding of participants. Of the selected studies, 4 used SMS text messaging, 1 used WhatsApp, and the remaining ones used specific smartphone apps. Weight loss and reduction in BMI were the most reported successful outcomes (reported in 4 studies). CONCLUSIONS: Evidence on the effectiveness of mobile health-based interventions in reducing the risk for cardiovascular disease and type 2 diabetes is low due to the quality of the studies and the small effects that were measured. This highlights the need for further high-quality research to investigate the potential of mobile health interventions. TRIAL REGISTRATION: International Prospective Register of Systematic Reviews (PROSPERO) CRD42019135405; https://www.crd.york.ac.uk/PROSPERO/display_record.php?RecordID=135405.
No takes yet. Share an insight, caveat, or question.
Buss et al. (2020) conducted a systematic review in Cardiovascular disease and type 2 diabetes mellitus. Mobile health technology (apps or SMS) vs. Standard care, waitlist, or in-person intervention was evaluated on Reduction in risk of cardiovascular disease and type 2 diabetes mellitus. Mobile health-based interventions showed low evidence of effectiveness in reducing the risk for cardiovascular disease and type 2 diabetes due to poor study quality and small measured effects.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: